Norbruis, O.F.

patient fliximab children study gastroenteriti disease treatment response hospital netherland therapy infection fliximab therapy rotaviru infusion hospitalization pathogen crohn ifx treatment month adult maintenance follow-up flammatory bowel disease bowel microbiol duration table fliximab infusions adjustment factor incidence number paediatric ef ficacy 5 years group cohort sample range control visit health difference 2 years duynhoven reaction result disease duration ifx failure risk factors admission paediatric cd patients episode virus outcome gastroenterol period diarrhea aliment pharmacol fliximab treatment fliximab dependency flammatory geops study kortbeek lm induction surgery symptom noroviru cryptosporidium fliximab maintenance treatment three-dose induction scheme koopmans mp diagnosis parasite vaccination dosing ifx therapy koopman treatment schedule